Cargando…

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen

Detalles Bibliográficos
Autores principales: Gotoh, Minoru, Kurokawa, Tomoya, Yonekura, Syuji, Okano, Mitsuhiro, Maekawa, Yuriko, Okamoto, Yoshitaka, Okubo, Kimihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086994/
https://www.ncbi.nlm.nih.gov/pubmed/36106517
http://dx.doi.org/10.1111/all.15514
_version_ 1785022249695182848
author Gotoh, Minoru
Kurokawa, Tomoya
Yonekura, Syuji
Okano, Mitsuhiro
Maekawa, Yuriko
Okamoto, Yoshitaka
Okubo, Kimihiro
author_facet Gotoh, Minoru
Kurokawa, Tomoya
Yonekura, Syuji
Okano, Mitsuhiro
Maekawa, Yuriko
Okamoto, Yoshitaka
Okubo, Kimihiro
author_sort Gotoh, Minoru
collection PubMed
description
format Online
Article
Text
id pubmed-10086994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100869942023-04-12 Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen Gotoh, Minoru Kurokawa, Tomoya Yonekura, Syuji Okano, Mitsuhiro Maekawa, Yuriko Okamoto, Yoshitaka Okubo, Kimihiro Allergy Letters John Wiley and Sons Inc. 2022-09-23 2023-02 /pmc/articles/PMC10086994/ /pubmed/36106517 http://dx.doi.org/10.1111/all.15514 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Gotoh, Minoru
Kurokawa, Tomoya
Yonekura, Syuji
Okano, Mitsuhiro
Maekawa, Yuriko
Okamoto, Yoshitaka
Okubo, Kimihiro
Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
title Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
title_full Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
title_fullStr Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
title_full_unstemmed Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
title_short Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
title_sort same dose of japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either japanese cedar or japanese cypress pollen
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086994/
https://www.ncbi.nlm.nih.gov/pubmed/36106517
http://dx.doi.org/10.1111/all.15514
work_keys_str_mv AT gotohminoru samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen
AT kurokawatomoya samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen
AT yonekurasyuji samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen
AT okanomitsuhiro samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen
AT maekawayuriko samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen
AT okamotoyoshitaka samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen
AT okubokimihiro samedoseofjapanesecedarpollensublingualimmunotherapytabletsisoptimalforallergicrhinitiscausedbyeitherjapanesecedarorjapanesecypresspollen